Through the process of developing bioactive small molecules, solubility determination is a crucial step. Many research papers treating problems related to solubility are published, but none of them fully describes the methods and steps for solubility assessment. In addition, in silico prediction tools and databases, such as SwissADME, ACD/Percepta, DrugBank and many others offer the possibility to have approximative solubility values based on the structure of the molecule. Although, significant differences can be observed depending on the database and the conditions of the experiment: solvent, pH, temperature… etc. The lack of data can be a barrier to obtaining details on solubility measurement methods. This presentation aims to describe, step by step, the journey of theophylline solubility determination using HPLC-DAD.
Previous Article in event
Molecular Docking Studies of 1,3,4-Thiadiazole Amidoalkyl Derivatives as Potential Inhibitors of Dihydrofolate Reductase.Previous Article in session
Next Article in event Next Article in session
The journey towards solubility assessment of small molecules using HPLC-DAD
Published: 01 November 2022 by MDPI in 8th International Electronic Conference on Medicinal Chemistry session General
Keywords: HPLC; in silico prediction; shake-flask; small molecules; solubility